This HTML5 document contains 106 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
n11http://dx.doi.org/10.4161/
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q41274844
rdf:type
wikibase:Item
schema:description
artigo científico bài báo khoa học 2012年论文 articolo scientifico מאמר מדעי 2012年の論文 2012年论文 tudományos cikk 2012年论文 научни чланак wissenschaftlicher Artikel vedecký článok επιστημονικό άρθρο vitskapeleg artikkel 2012年論文 article scientific мақолаи илмӣ artikel ilmiah artículu científicu espublizáu en 2012 wetenschappelijk artikel videnskabelig artikel научная статья article científic наукова стаття, опублікована в жовтні 2012 บทความทางวิทยาศาสตร์ 2012年論文 artikulong pang-agham vitenskapelig artikkel vědecký článek naučni članak 2012年论文 სამეცნიერო სტატია articol științific scientific article published on October 2012 teaduslik artikkel 2012年論文 scienca artikolo 2012년 논문 artigo científico научна статия bilimsel makale 2012年論文 artículo científico publicado en 2012 مقالة علمية نشرت في أكتوبر 2012 tieteellinen artikkeli 2012年论文 vetenskaplig artikel অক্টোবর ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ scientific article published on October 2012 artikull shkencor научни чланак article scientifique 2012年論文 scientific article published on October 2012 2012年论文 2012 nî lūn-bûn artigo científico artykuł naukowy
p:P577
wds:Q41274844-854B6369-B98C-4ADC-8B43-206E90DED024
wdt:P577
2012-10-01T00:00:00Z
p:P2860
wds:Q41274844-A00F3218-6C64-40DA-91FD-25B9EE646689 wds:Q41274844-09F8C9EC-3FDD-4C21-9C46-26BAB2B75334 wds:Q41274844-2A1FC0A7-E2A0-4221-B733-E6B821737A68 wds:Q41274844-4B3262D3-C386-418F-9B92-7937A90A0455 wds:Q41274844-AE002E79-6642-4AA4-8A41-39B048131ED7 wds:Q41274844-C969AC4F-FCA8-451B-8252-13231550BCA0 wds:Q41274844-7399A849-32E3-4630-8621-4C6DB35F55C5
wdt:P2860
wd:Q34582536 wd:Q24644442 wd:Q48427915 wd:Q33815795 wd:Q46126574 wd:Q48594003 wd:Q48308116
p:P2093
wds:Q41274844-8B8D40F0-F927-494A-827B-06B777A05D88
wdt:P2093
Kim Margolin
rdfs:label
Ipilimumab in a Phase II trial of melanoma patients with brain metastases
skos:prefLabel
Ipilimumab in a Phase II trial of melanoma patients with brain metastases
schema:name
Ipilimumab in a Phase II trial of melanoma patients with brain metastases
p:P1476
wds:Q41274844-8FF9BF66-43B0-4AAE-9F05-334043C59A62
wdt:P1476
Ipilimumab in a Phase II trial of melanoma patients with brain metastases
p:P304
wds:Q41274844-26885E5D-4B37-4D87-8682-6A87C0091875
wdt:P304
1197-1199
p:P31
wds:Q41274844-AC9A2C66-59E3-46EF-B6B9-A0229A66580B
wdt:P31
wd:Q13442814
p:P921
wds:Q41274844-24F8D75A-7A1E-4A0B-A511-2F2D56A8BA36 wds:Q41274844-72058966-FE7B-4341-8D5B-79A621BA8FEE
wdt:P921
wd:Q42824440 wd:Q2459042
p:P698
wds:Q41274844-FC866D44-00BA-4986-B0AC-3E349EFC72EA
wdtn:P698
n8:23170278
wdt:P698
23170278
p:P1433
wds:Q41274844-BE745520-4E24-4386-BDF9-CF797EFEB540
wdt:P1433
wd:Q18026500
p:P433
wds:Q41274844-A429D6E5-3877-4F20-A4FB-B7EC17430083
p:P478
wds:Q41274844-68FDE66C-165B-4CD5-9BED-3D6EFD4D97AF
wdt:P433
7
wdt:P478
1
p:P356
wds:Q41274844-C5DC8112-C9E2-4A13-A781-585BF1EF519C
wdtn:P356
n11:ONCI.20687
wdt:P356
10.4161/ONCI.20687
p:P5875
wds:Q41274844-F8C9A6D3-10C1-438B-BCD0-0EABF59A3082
wdt:P5875
233739139
p:P932
wds:Q41274844-3A2888CA-3A87-403C-9C0B-D3464E82B309
wdt:P932
3494644